Old Mutual Customised Solutions’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$777K Buy
7,500
+1,200
+19% +$121K 0.08% 295
2018
Q1
$620K Hold
6,300
0.06% 343
2017
Q4
$534K Buy
6,300
+2,800
+80% +$231K 0.05% 379
2017
Q3
$269K Hold
3,500
0.04% 478
2017
Q2
$273K Hold
3,500
0.04% 467
2017
Q1
$252K Hold
3,500
0.04% 478
2016
Q4
$217K Buy
3,500
+1,100
+46% +$67.4K 0.04% 486
2016
Q3
$155K Buy
2,400
+700
+41% +$46.6K 0.04% 451
2016
Q2
$107K Hold
1,700
0.03% 605
2016
Q1
$98K Hold
1,700
0.03% 601
2015
Q4
$91K Hold
1,700
0.02% 610
2015
Q3
$87K Buy
1,700
+200
+13% +$10.8K 0.02% 623
2015
Q2
$85K Hold
1,500
0.02% 656
2015
Q1
$108K Buy
1,500
+1,100
+275% +$71.4K 0.03% 612
2014
Q4
$22K Buy
+400
New +$20.9K 0.01% 699
2014
Q3
Sell
-800
Closed -$41K 733
2014
Q2
$41K Hold
800
0.01% 707
2014
Q1
$36K Hold
800
0.01% 721
2013
Q4
$38K Hold
800
0.01% 723
2013
Q3
$42K Hold
800
0.01% 704
2013
Q2
$36K Buy
+800
New +$38K 0.01% 836

Other funds holding RMD

Old Mutual Customised Solutions's RMD Position: Q2 2018 in Review

Old Mutual Customised Solutions increased its ResMed (RMD) stake by 19% in Q2 2018, buying an estimated $121K and bringing the position to 7,500 shares worth $777K. The position accounts for 0.08% of the portfolio, ranked #295.

Old Mutual Customised Solutions first reported a position in RMD in Q2 2013 and has held it in 20 quarters since. 465 funds tracked by Wall St. Rank hold RMD as of Q2 2018.

  • Old Mutual Customised Solutions held 7,500 shares of ResMed worth $777K as of Q2 2018.
  • Old Mutual Customised Solutions bought 1,200 ResMed shares in Q2 2018, an estimated $121K.
  • ResMed made up 0.08% of Old Mutual Customised Solutions's portfolio in Q2 2018, its #295 holding.
  • Old Mutual Customised Solutions first reported a position in ResMed in Q2 2013 and has held it in 20 quarters since.
  • 465 funds tracked by Wall St. Rank held ResMed as of Q2 2018.

Based on Old Mutual Customised Solutions's 13F filing for Q2 2018, filed 14 Aug 2018.